Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - CYTYC Corporation (NasdaqNM:CYTC)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
July 26Price hit new 52-week high ($27.01)
Location
85 Swanson Road
Boxborough, MA 01719
Phone: (978) 263-8000
Fax: (978) 635-1033
Email: webmaster@cytyc.com
Employees (last reported count): 457
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Scientific & Technical Instr.
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 27%
·Over the last 6 months:
 · 4 insider sells; 201.0K shares
  (0.6% of insider shares)
·Institutional: 89% (121% of float)
(445 institutions)
·Net Inst. Selling: 2.14M shares (+2.14%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
CYTYC Corporation designs, develops, manufactures and markets a sample preparation system for medical diagnostic applications. The Company's ThinPrep System allows for the automated preparation of cervical cell specimens on microscope slides for use in cervical cancer screening, as well as for the automated preparation of other cell specimens on microscope slides for use in non-gynecological testing applications. The product has been approved as a replacement for the conventional Pap smear method. Its product labeling also includes the claim that the ThinPrep System is significantly more effective in detecting Low Grade Squamous Intraepithelial Lesions (LGSIL) and more severe lesions than the conventional Pap smear method in a variety of patient populations.
More from Market Guide: Expanded Business Description

Financial Summary
CYTYC Corporation designs, develops, manufactures and markets a sample preparation system for medical diagnostic applications. For the six months ended 6/30/01, net sales rose 61% to $100.5 million. Net income totaled $31.6 million, up from $12.4 million. Revenues reflect increased sales of the Company's ThinPrep Pap Test for cervical cancer screening in the United States. Earnings also benefited from higher operating margins and $3.1 million in litigation income.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Monroe Trout, M.D., 70
Chairman
--  --  
Patrick Sullivan, 49
Vice Chairman, Pres, CEO
$808K$6.2M
C. William McDaniel, 60
Vice Chairman
--  --  
Robert Bowen, 51
CFO, VP, Treasurer
--  --  
Daniel Levangie, 50
COO, Exec. VP
479K7.6M
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CYTCAs of 31-Aug-2001
Price and Volume
52-Week Low
on 18-Sep-2000
$11.25 
Recent Price$24.23 
52-Week High
on 26-July-2001
$27.01 
Beta1.99 
Daily Volume (3-month avg)1.06M
Daily Volume (10-day avg)734.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+70.0%
52-Week Change
relative to S&P500
+128.1%
Share-Related Items
Market Capitalization$2.80B
Shares Outstanding115.6M
Float84.4M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 1 on 5-Mar-2001
Per-Share Data
Book Value (mrq)$1.80 
Earnings (ttm)$0.48 
Earnings (mrq)$0.13 
Sales (ttm)$1.51 
Cash (mrq)$1.11 
Valuation Ratios
Price/Book (mrq)13.44 
Price/Earnings (ttm)50.37 
Price/Sales (ttm)16.01 
Income Statements
Sales (ttm)$180.2M
EBITDA (ttm)$66.0M
Income available to common (ttm)$57.3M
Profitability
Profit Margin (ttm)31.8%
Operating Margin (ttm)33.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)32.04%
Return on Equity (ttm)36.59%
Financial Strength
Current Ratio (mrq)8.18 
Debt/Equity (mrq)0 
Total Cash (mrq)$128.1M
Short Interest
As of 8-Aug-2001
Shares Short8.17M
Percent of Float9.7%
Shares Short
(Prior Month)
8.56M
Short Ratio6.37 
Daily Volume1.28M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.